Search
ICU Medical Inc
ICUIAdd to Watchlist
146.600USD
-1.330-0.90%
Close 06/30, 16:00（ET）Quotes delayed by 15 min
3.66BMarket Cap
78.10P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-0.90%
5 Days
+8.18%
1 Month
+8.28%
6 Months
+2.75%
Year to Date
+2.75%
1 Year
+10.93%
Key Figures
147.930Open
148.318High
171.02KVolume
78.10P/E TTM
15.30P/E Dynamic
--Dividend TTM
0.69%Turnover Ratio
147.930Prev. Close
143.855Low
18.98MTurnover
LossP/E Static
1.70P/B
0.00%Div Yield TTM
1.13%ROA
160.29052wk High
0.39Volume Ratio
-117.69MNet Profit
24.69MShares
1.8772EPS TTM
0.78Beta
2.26%ROE
107.00052wk Low
3.02%Amplitude
38.89%Gross Margin
3.66BMarket Cap
5.99Reward/Risk
2.06%Risk Rate
TradingKey Stock Score of ICU Medical Inc
Currency: USD Updated: 2026-06-30Key Insights
ICU Medical Inc's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 25 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 171.71.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
ICU Medical Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
ICU Medical Inc Highlights
StrengthsRisks
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 78.10, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 28.59M shares, increasing 2.18% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 27.83K shares of this stock.
Analyst Rating
Based on
7
analysts
Buy
Current Rating
171.714
Target Price
+16.08%
Upside Space
ICU Medical Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
ICU Medical Inc Info
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
Ticker SymbolICUI
CompanyICU Medical Inc
CEOJain (Vivek)
Websitehttps://www.icumed.com/
Related Instruments
-1.10%
-1.12%
-2.20%
-2.04%
-1.28%
-0.15%
-4.84%
-3.35%
-0.64%
-0.36%
-1.11%
-1.86%
+0.49%
-0.86%
-0.43%
+2.15%
-2.57%
-1.77%
-0.32%
-0.03%Popular Instruments
52176.500
-19.800 (-0.04%)
30095.100
-129.500 (-0.43%)
7469.800
-12.600 (-0.17%)
15297.000
-298.000 (-1.91%)
70621.000
-235.000 (-0.33%)
6319.500
-7.500 (-0.12%)
68.628
-1.293 (-1.85%)
289.360
+7.620 (+2.70%)
200.090
+5.120 (+2.63%)
3983.440
-23.840 (-0.59%)
FAQs
What is the current price of ICU Medical Inc (ICUI)?
The current price of ICU Medical Inc (ICUI) is 146.60.
What is the symbol of ICU Medical Inc?
The ticker symbol of ICU Medical Inc is ICUI.
What is the 52-week high of ICU Medical Inc?
The 52-week high of ICU Medical Inc is 160.29.
What is the 52-week low of ICU Medical Inc?
The 52-week low of ICU Medical Inc is 107.00.
What is the market capitalization of ICU Medical Inc?
The market capitalization of ICU Medical Inc is 3.62B.
Is ICU Medical Inc (ICUI) currently rated as Buy, Hold, or Sell?
According to analysts, ICU Medical Inc (ICUI) has an overall rating of Buy, with a price target of 171.71.
What is the Earnings Per Share (EPS TTM) of ICU Medical Inc (ICUI)?
The Earnings Per Share (EPS TTM) of ICU Medical Inc (ICUI) is 0.03.